Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort study
View ORCID ProfileXiaolong Qi, Yanna Liu, Jonathan A. Fallowfield, Jitao Wang, Jianwen Wang, Xinyu Li, Jindong Shi, Hongqiu Pan, Shengqiang Zou, Hongguang Zhang, Zhenhuai Chen, Fujian Li, Yan Luo, Mei Mei, Huiling Liu, Zhengyan Wang, Jinlin Li, Hua Yang, Huihua Xiang, Xiaodan Li, Tao Liu, Ming-Hua Zheng, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Ning Kang, Qing He, Ye Gu, Guo Zhang, Chuxiao Shao, Dengxiang Liu, Lin Zhang, Xun Li, Norifumi Kawada, Zicheng Jiang, Fengmei Wang, Bin Xiong, Tetsuo Takehara, Don C. Rockey, for the COVID-Cirrhosis-CHESS Group
doi: https://doi.org/10.1101/2020.04.24.20072611
Xiaolong Qi
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Yanna Liu
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Jonathan A. Fallowfield
2Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
Jitao Wang
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
3CHESS-COVID-19 Group, Xingtai People’s Hospital, Xingtai, China
Jianwen Wang
4Department of Tuberculosis and Respiratory, Wuhan Jinyintan Hospital, Wuhan, China
Xinyu Li
5Department of Infectious Disease, Shanghai Fifth People’s Hospital of Fudan University, Shanghai, China
Jindong Shi
6Department of Respiratory Medicine, Shanghai Fifth People’s Hospital of Fudan University, Shanghai, China
Hongqiu Pan
7Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China
Shengqiang Zou
7Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China
Hongguang Zhang
7Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China
Zhenhuai Chen
8Department of Respiratory Medicine, The People’s Hospital of Baoding, Baoding, China
Fujian Li
8Department of Respiratory Medicine, The People’s Hospital of Baoding, Baoding, China
Yan Luo
9Department of Gastroenterology, Tianjin Haihe Hospital, Tianjin, China
Mei Mei
9Department of Gastroenterology, Tianjin Haihe Hospital, Tianjin, China
Huiling Liu
9Department of Gastroenterology, Tianjin Haihe Hospital, Tianjin, China
Zhengyan Wang
10Departments of Respiratory Medicine, Suizhou Hospital, Hubei University of Medicine, Suizhou, China
Jinlin Li
10Departments of Respiratory Medicine, Suizhou Hospital, Hubei University of Medicine, Suizhou, China
Hua Yang
11Departments of Respiratory Medicine, Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, Hubei, China
Huihua Xiang
12Department of Radiology, Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, Hubei, China
Xiaodan Li
13Department of Infectious Disease, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, Hubei, China
Tao Liu
13Department of Infectious Disease, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, Hubei, China
Ming-Hua Zheng
14Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Chuan Liu
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Yifei Huang
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Dan Xu
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Xiaoguo Li
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Ning Kang
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Qing He
15CHESS-COVID-19 Group, The Third People’s Hospital of Shenzhen, Shenzhen, China
Ye Gu
16CHESS-COVID-19 Group, The Sixth People’s Hospital of Shenyang, Shenyang, China
Guo Zhang
17CHESS-COVID-19 Group, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
Chuxiao Shao
18CHESS-COVID-19 Group, Zhejiang University Lishui Hospital & Lishui Central Hospital, Lishui, China
Dengxiang Liu
3CHESS-COVID-19 Group, Xingtai People’s Hospital, Xingtai, China
Lin Zhang
19Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China
Xun Li
1CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Norifumi Kawada
20Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan
Zicheng Jiang
21Department of Infectious Disease, Ankang Central Hospital, Ankang, China
Fengmei Wang
22Department of Gastroenterology and Hepatology, Tianjin Second People’s Hospital, Tianjin, China
Bin Xiong
23Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Tetsuo Takehara
24Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan
Don C. Rockey
25Division of Gastroenterology and Hepatology, Medical University South Carolina, Charleston, South Carolina, USA
Article usage
Posted April 28, 2020.
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort study
Xiaolong Qi, Yanna Liu, Jonathan A. Fallowfield, Jitao Wang, Jianwen Wang, Xinyu Li, Jindong Shi, Hongqiu Pan, Shengqiang Zou, Hongguang Zhang, Zhenhuai Chen, Fujian Li, Yan Luo, Mei Mei, Huiling Liu, Zhengyan Wang, Jinlin Li, Hua Yang, Huihua Xiang, Xiaodan Li, Tao Liu, Ming-Hua Zheng, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Ning Kang, Qing He, Ye Gu, Guo Zhang, Chuxiao Shao, Dengxiang Liu, Lin Zhang, Xun Li, Norifumi Kawada, Zicheng Jiang, Fengmei Wang, Bin Xiong, Tetsuo Takehara, Don C. Rockey, for the COVID-Cirrhosis-CHESS Group
medRxiv 2020.04.24.20072611; doi: https://doi.org/10.1101/2020.04.24.20072611
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort study
Xiaolong Qi, Yanna Liu, Jonathan A. Fallowfield, Jitao Wang, Jianwen Wang, Xinyu Li, Jindong Shi, Hongqiu Pan, Shengqiang Zou, Hongguang Zhang, Zhenhuai Chen, Fujian Li, Yan Luo, Mei Mei, Huiling Liu, Zhengyan Wang, Jinlin Li, Hua Yang, Huihua Xiang, Xiaodan Li, Tao Liu, Ming-Hua Zheng, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Ning Kang, Qing He, Ye Gu, Guo Zhang, Chuxiao Shao, Dengxiang Liu, Lin Zhang, Xun Li, Norifumi Kawada, Zicheng Jiang, Fengmei Wang, Bin Xiong, Tetsuo Takehara, Don C. Rockey, for the COVID-Cirrhosis-CHESS Group
medRxiv 2020.04.24.20072611; doi: https://doi.org/10.1101/2020.04.24.20072611
Subject Area
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (652)
- Anesthesia (174)
- Cardiovascular Medicine (2527)
- Dermatology (211)
- Emergency Medicine (387)
- Epidemiology (12005)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3920)
- Geriatric Medicine (368)
- Health Economics (655)
- Health Informatics (2536)
- Health Policy (978)
- Hematology (353)
- HIV/AIDS (814)
- Medical Education (390)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3681)
- Nursing (205)
- Nutrition (548)
- Oncology (1915)
- Ophthalmology (558)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1078)
- Primary Care Research (436)
- Public and Global Health (6354)
- Radiology and Imaging (1342)
- Respiratory Medicine (847)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (180)
- Urology (157)